Use access key #2 to skip to page content.
$9.04 -0.11 (-1.20%)
8/21/2008 4:00 PM

Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating:
*****

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ENZN

Add Stock to Watchlist

What the Community Thinks

Total Members

81 Outperforms
4 Underperforms
 

All-Stars

22 Outperforms
1 Underperforms
 

Wall Street

2 Outperforms
0 Underperforms
 

Members bullish on ENZN are also bullish on:

Members bearish on ENZN are also bearish on:

Ticker Tags

Biotechnology (294), Micro Cap (4824)
Suggest a tag

Enzon Pharmaceuticals, Inc. At A Glance

Current Price: $9.04
Last Trade Time: 8/21/2008 4:00 PM
Open: $9.06
Previous Close: $9.15
Daily Range: $8.88 - $9.19
52-Week Range: $6.92 - $10.36
Volume: 283,762
Market Cap: $410.62M
P/E Ratio: 4.60
Compare Our Special Broker Offers!

Stock Trends

ENZN VS S&P 500 (SPY)

ENZN 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for ENZN

More Headlines...

Top Bull Pitch

Recs

1

Enzon Pharmaceuticals, Inc. (ENZN)

Avatar LarkinSoft (< 20) Submitted: 10/09/06 7:45 PM

Nearly 100% of the stock is in the hands of institutional traders, all purchased near the bottom. Riding the smart money's coattails is a sure winner. This stock will double within 24 months.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 13 :   1 2 3 Next »

Recs

0

 (ENZN)

Avatar pjani06 (86.02) Submitted: 7/26/08 12:33 PM : Outperform Start Price: $7.50 ENZN Score: 18.71

Our demographic picture as well as increased attention to prolonged life will allow this company to easily hit revenues beyond 400 million at the very least within next 5 years. apply a simple 20% oper margin, less potential future debt exp of $40 mil, and you have at least $40 mill left over in net income. multiply that by 10 for a high growth biotech/pharma and this company should be worth atleast $400mill today

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENZN)

Avatar JonAtkins57 (53.28) Submitted: 6/27/08 12:26 PM : Outperform Start Price: $7.47 ENZN Score: 21.39

Market Cap >100M and <1B
P/E Ratio < 10
Div Yield < 1%
52w % Change < 20%
Net Profit Margin % > 20
Gross Margin % > 20
Current Ratio > 1
EPS > 0

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENZN)

Avatar hennessy7 (< 20) Submitted: 5/26/08 9:12 AM : Outperform Start Price: $8.85 ENZN Score: 9.40

I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other sectors so I am sticking to high risk/ high reward opportunities.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENZN)

Avatar WonderWolf (52.59) Submitted: 5/20/08 11:48 PM : Outperform Start Price: $8.88 ENZN Score: 11.68

Working on 2 cancer drugs and will be the big winner!!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENZN)

Avatar Addgirl48 (45.03) Submitted: 3/29/08 11:21 AM : Outperform Start Price: $9.28 ENZN Score: 0.07

People all ways needing pills so Pharmaceuticals all ways geting business and all ways will

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 13 :   1 2 3 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackIcahn 89.25 09/30/07 Outperform NS $8.81+2.61%-16.24%+18.85 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 90.23 09/30/07 Outperform NS $8.81+2.61%-16.24%+18.85 Toggle the visibility of 60-Second Pitch and replies

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners